Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess

Abstract Nonclassic apparent mineralocorticoid excess (NC-AME) is proposed as a novel clinical condition with a mild phenotypic spectrum that ranges from normotension to severe hypertension. This condition is mainly characterized by a high serum cortisol to cortisone ratio (F/E) and concomitant low...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alejandra Tapia-Castillo, Cristian A. Carvajal, Xaviera López-Cortés, Andrea Vecchiola, Carlos E. Fardella
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d585c5602e864731b30d1b58ec5cb65e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d585c5602e864731b30d1b58ec5cb65e
record_format dspace
spelling oai:doaj.org-article:d585c5602e864731b30d1b58ec5cb65e2021-12-02T19:02:35ZNovel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess10.1038/s41598-021-96628-62045-2322https://doaj.org/article/d585c5602e864731b30d1b58ec5cb65e2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96628-6https://doaj.org/toc/2045-2322Abstract Nonclassic apparent mineralocorticoid excess (NC-AME) is proposed as a novel clinical condition with a mild phenotypic spectrum that ranges from normotension to severe hypertension. This condition is mainly characterized by a high serum cortisol to cortisone ratio (F/E) and concomitant low cortisone (E), however further metabolic changes in NC-AME have not been studied. A cross-sectional study was performed in a primary-care cohort of 396 Chilean subjects, which were classified in two groups: NC-AME (n = 28) and healthy controls (n = 27). A discovery study based in untargeted metabolomics assay in serum samples from both groups was performed by UPLC-Q-TOF/MS. Global metabolomic variations were assayed by principal component analysis and further compared by orthogonal partial least-squares discriminant analysis (OPLS-DA). NC-AME subjects exhibited higher values of blood pressure, fractional excretion of potassium, and lower plasma renin activity and urinary sodium to potassium ratio. Metabolomic analyses showed 36 differentially regulated metabolites between NC-AME and control subjects. A ROC curve analyses identified eight metabolites with high discriminatory capacity between NC-AME and control subjects. Moreover, gamma-l-glutamyl-l-methionine sulfoxide and 5-sulfoxymethylfurfural, exhibited significant association with cortisone, which are potential biomarkers of NC-AME, however further assays should elucidate its biological role in setup and progression of this phenotype.Alejandra Tapia-CastilloCristian A. CarvajalXaviera López-CortésAndrea VecchiolaCarlos E. FardellaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alejandra Tapia-Castillo
Cristian A. Carvajal
Xaviera López-Cortés
Andrea Vecchiola
Carlos E. Fardella
Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
description Abstract Nonclassic apparent mineralocorticoid excess (NC-AME) is proposed as a novel clinical condition with a mild phenotypic spectrum that ranges from normotension to severe hypertension. This condition is mainly characterized by a high serum cortisol to cortisone ratio (F/E) and concomitant low cortisone (E), however further metabolic changes in NC-AME have not been studied. A cross-sectional study was performed in a primary-care cohort of 396 Chilean subjects, which were classified in two groups: NC-AME (n = 28) and healthy controls (n = 27). A discovery study based in untargeted metabolomics assay in serum samples from both groups was performed by UPLC-Q-TOF/MS. Global metabolomic variations were assayed by principal component analysis and further compared by orthogonal partial least-squares discriminant analysis (OPLS-DA). NC-AME subjects exhibited higher values of blood pressure, fractional excretion of potassium, and lower plasma renin activity and urinary sodium to potassium ratio. Metabolomic analyses showed 36 differentially regulated metabolites between NC-AME and control subjects. A ROC curve analyses identified eight metabolites with high discriminatory capacity between NC-AME and control subjects. Moreover, gamma-l-glutamyl-l-methionine sulfoxide and 5-sulfoxymethylfurfural, exhibited significant association with cortisone, which are potential biomarkers of NC-AME, however further assays should elucidate its biological role in setup and progression of this phenotype.
format article
author Alejandra Tapia-Castillo
Cristian A. Carvajal
Xaviera López-Cortés
Andrea Vecchiola
Carlos E. Fardella
author_facet Alejandra Tapia-Castillo
Cristian A. Carvajal
Xaviera López-Cortés
Andrea Vecchiola
Carlos E. Fardella
author_sort Alejandra Tapia-Castillo
title Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
title_short Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
title_full Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
title_fullStr Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
title_full_unstemmed Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
title_sort novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d585c5602e864731b30d1b58ec5cb65e
work_keys_str_mv AT alejandratapiacastillo novelmetabolomicprofileofsubjectswithnonclassicapparentmineralocorticoidexcess
AT cristianacarvajal novelmetabolomicprofileofsubjectswithnonclassicapparentmineralocorticoidexcess
AT xavieralopezcortes novelmetabolomicprofileofsubjectswithnonclassicapparentmineralocorticoidexcess
AT andreavecchiola novelmetabolomicprofileofsubjectswithnonclassicapparentmineralocorticoidexcess
AT carlosefardella novelmetabolomicprofileofsubjectswithnonclassicapparentmineralocorticoidexcess
_version_ 1718377238858039296